Drug makers fight Calif. price caps

Published



The pharmaceutical industry is taking its fight against the effort to rein in soaring drug prices to the state level, shelling out more than $60 million to fight a ballot measure in California.

The measure would install price caps on drugs that any state agency buys. The price for a product would be tied to the price paid by the Department of Veterans Affairs, which is able to negotiate with drugmakers for cheaper products.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.